Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a hidden neck incision make cyst removal Scar-Free?

NCT ID NCT07778485

Disease control Sponsor: People's Hospital of Anshun City of Guizhou Province Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether a minimally invasive technique, using a small hidden incision under the chin, can remove thyroglossal duct cysts as effectively as traditional open surgery but with less visible scarring. Sixty patients with these congenital neck cysts will be randomly assigned to either the new endoscopic-assisted procedure or the standard Sistrunk operation. Researchers will compare operation time, blood loss, hospital stay, pain, complications, and scar appearance to see if the new approach offers a better cosmetic outcome without compromising safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Submental endoscopic-assisted Sistrunk operation (a minimally invasive surgical procedure using a small hidden incision under the chin)
What this could lead to
If successful, this could offer a scar-free alternative to traditional neck surgery for thyroglossal duct cysts, improving cosmetic results and patient satisfaction.
What could go wrong
This is a small, early-stage trial, and the new technique may not be suitable for all patients. Risks include potential complications like infection, nerve injury, or cyst recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The cyst is in the non-acute infection stage; * The cyst has not ruptured to form a skin sinus tract or fistula; * Preoperative B-ultrasound and CT indicated that it was a thyroglossal duct cyst; * There are no severe underlying heart or lung diseases or coagulation dysfunction; * The patient and their family voluntarily chose to undergo laparoscopic resection of the thyroglossal duct cyst; ⑥ The patient and their family voluntarily signed the informed consent form. Exclusion Criteria: * The cyst is in the acute infection stage; * The cyst ruptures, forming a skin sinus tract or fistula; ③ Has severe underlying heart and lung diseases and coagulation dysfunction; ④ Those with cyst diameters greater than 4 cm; ⑤ Those currently participating in other research studies.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Thyroglossal cyst are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thyroglossal duct cyst

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Thyroglossal cyst

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.